Keiichi Yonemori
- Co-authors
- Kosei MaemuraHiroshi KuraharaShoji NatsugoeY IshidouYusaku OsakoYoshiaki KitaS MatsunagaNaohiko Seki
- Topics
- MicroRNA in disease regulation (6 papers)RNA modifications and cancer (5 papers)Pancreatic and Hepatic Oncology Research (2 papers)
- Journals
- BoneOncotargetCancer Science
- Partner nations
- JapanSwedenUnited States
In The Last Decade
Keiichi Yonemori
13 papers receiving 663 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 393
- Cancer Research 282
- Surgery 145
- Oncology 140
- Pathology and Forensic Medicine 97
Countries citing papers authored by Keiichi Yonemori
This map shows the geographic impact of Keiichi Yonemori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Yonemori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Yonemori more than expected).
Fields of papers citing papers by Keiichi Yonemori
This network shows the impact of papers produced by Keiichi Yonemori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Yonemori. The network helps show where Keiichi Yonemori may publish in the future.
Co-authorship network of co-authors of Keiichi Yonemori
This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Yonemori. A scholar is included among the top collaborators of Keiichi Yonemori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Yonemori. Keiichi Yonemori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 49 | |
| 3 | 70 | |
| 4 | 14 | |
| 5 | 46 | |
| 6 | 117 | |
| 7 | 58 | |
| 8 | 46 | |
| 9 | [A case of rectal cancer which showed complete response to chemotherapy for para-aortic lymph node metastases remaining after surgery, for which resection of Virchow's lymph node recurrence led to long-term survival]. | 1 |
| 10 | 13 | |
| 11 | 84 | |
| 12 | Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. | 81 |
| 13 | 81 |
About Keiichi Yonemori
Keiichi Yonemori is a scholar working on Cancer Research, Pathology and Forensic Medicine and Biophysics, having authored 13 papers that have together received 671 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (5 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Cancer Research (282 citations), Molecular Biology (393 citations) and Pathology and Forensic Medicine (97 citations). Keiichi Yonemori has collaborated with scholars based in Japan, Sweden and United States. Frequent co-authors include Kosei Maemura, Hiroshi Kurahara, Shoji Natsugoe, Y Ishidou, Yusaku Osako, Yoshiaki Kita, S Matsunaga, Shoji Natsugoe, Naohiko Seki and Satoshi Maeda. Their work appears in journals such as Bone, Oncotarget and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.